These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14766679)

  • 1. Increased endothelin-1 production in patients with chronic heart failure.
    Parker JD; Thiessen JJ
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1141-5. PubMed ID: 14766679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human endothelin-1 clearance kinetics revealed by a radiotracer technique.
    Parker JD; Thiessen JJ; Reilly R; Tong JH; Stewart DJ; Pandey AS
    J Pharmacol Exp Ther; 1999 Apr; 289(1):261-5. PubMed ID: 10087013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1.
    von Lueder TG; Kjekshus H; Edvardsen T; ØIe E; Urheim S; Vinge LE; Ahmed MS; Smiseth OA; Attramadal H
    Cardiovasc Res; 2004 Jul; 63(1):41-50. PubMed ID: 15194460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
    Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal neurohumoral responses to exercise in patients with heart disease: inhibition of an increase in endothelin-1 production during exercise.
    Ishikawa S; Miyauchi T; Ueno M; Sagawa K; Sakai S; Ushinohama H; Kado H; Sunagawa H; Goto K; Sugishita Y; Honda S
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S406-11. PubMed ID: 9595498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ET: pulmonary release of ET contributes to increased plasma ET levels and vasoconstriction in CHF.
    Kjekshus H; Smiseth OA; Klinge R; Oie E; Hystad ME; Attramadal H
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1299-310. PubMed ID: 10749728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of ET(B) receptor, but not ET(A) receptor, in congestive lung secondary to heart failure. Are marked increases in circulating endothelin-1 partly attributable to decreases in lung ET(B) receptor-mediated clearance of endothelin-1?
    Kobayshi T; Miyauchi T; Sakai S; Maeda S; Yamaguchi I; Goto K; Sugishita Y
    Life Sci; 1998; 62(2):185-93. PubMed ID: 9488116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
    Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced pulmonary clearance of endothelin in congestive heart failure: a marker of secondary pulmonary hypertension.
    Staniloae C; Dupuis J; White M; Gosselin G; Dyrda I; Bois M; Crépeau J; Bonan R; Caron A; Lavoie J
    J Card Fail; 2004 Oct; 10(5):427-32. PubMed ID: 15470654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activity of pulmonary endothelin converting enzyme in heart failure: relation to endothelin biosynthesis and receptor distribution.
    Ergul A; Grubbs AL; Zhang Y; Joffs C; Sample JA; King MK; Spinale FG
    J Card Fail; 2001 Mar; 7(1):84-91. PubMed ID: 11264554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced pulmonary metabolism of endothelin-1 in canine tachycardia-induced heart failure.
    Dupuis J; Moe GW; Cernacek P
    Cardiovasc Res; 1998 Sep; 39(3):609-16. PubMed ID: 9861303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart.
    Sakai S; Miyauchi T; Sakurai T; Kasuya Y; Ihara M; Yamaguchi I; Goto K; Sugishita Y
    Circulation; 1996 Mar; 93(6):1214-22. PubMed ID: 8653844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of desipramine on norepinephrine clearance in congestive heart failure.
    Clemson B; Baily RG; Davis D; Zelis R
    Am J Physiol; 1990 Aug; 259(2 Pt 1):E261-5. PubMed ID: 2200276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
    Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
    Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin in human congestive heart failure.
    Wei CM; Lerman A; Rodeheffer RJ; McGregor CG; Brandt RR; Wright S; Heublein DM; Kao PC; Edwards WD; Burnett JC
    Circulation; 1994 Apr; 89(4):1580-6. PubMed ID: 8149524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
    Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR
    Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous endothelin-1 depresses left ventricular systolic and diastolic performance in congestive heart failure.
    Onishi K; Ohno M; Little WC; Cheng CP
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1214-22. PubMed ID: 10027861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and therapeutic potential of the endothelin system in patients with chronic heart failure.
    Krum H; Denver R; Tzanidis A; Martin P
    Heart Fail Rev; 2001 Dec; 6(4):341-52. PubMed ID: 11447309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.